Vitreous Changes in Retinopathy of Prematurity

  • T. Hirose
  • D. N. Sang


The incidence of retinopathy of prematurity (ROP) appears to have increased in recent years because high-risk infants who might have died some years ago continue to survive as a result of improved neonatal care (1). One of the most important factors for development of ROP is the alteration of intrauterine developmental events leading to prematurity (2) that cannot be controlled once a child is born.


Retinal Detachment Vitreous Cavity Posterior Vitreous Detachment Rhegmatogenous Retinal Detachment Peripheral Retina 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. (1).
    PHELPS, D.L. — Retinopathy of prematurity: an estimate of vision loss in the United States, 1979. Pediatrics, 1981, 67, 924–925.PubMedGoogle Scholar
  2. (2).
    PATZ, A. — Observations on the retinopathy of prematurity. Am. J. Ophthalmol., 1985, 100, 164–168.PubMedGoogle Scholar
  3. (3).
    THE COMMITTEE FOR THE CLASSIFICATION OF RETINOPATHY OF PREMATURITY. — An international classification of retinopathy of prematurity. Arch. Ophthalmol., 1984, 102, 1130–1134.CrossRefGoogle Scholar
  4. (4).
    CANTOLINO, S. J., OGRADY, G.E., HERRERA, J. A., ISRAEL, C., JUSTICE, J., FLYNN, J. T. — Ophthalmoscopic monitoring of oxygen therapy in premature infants: fluorescein angiography in acute retrolental fibroplasia. Am. J. Ophthalmol., 1971, 72, 322–331.PubMedGoogle Scholar
  5. (5).
    FOOS, R.Y. — Chronic retinopathy of prematurity. Ophthalmology, 1985, 92, 563–574.PubMedGoogle Scholar
  6. (6).
    SANG, D.N., HUGHES, M.S., HIROSE, T., SOQUE, J., ALBERT, D.M., CRAFT, J. — The role of the vitreous gel in cicatricial retrolental fibroplasia. Invest. Ophthalmol. Vis. Sci., 1986, 27 (ARVO suppl.), 197.Google Scholar
  7. (7).
    SCHEPENS, C. L. — Clinical and research aspects of subtotal open-sky vitrectomy. Am. J. Ophthalmol, 1981, 91, 143–171.PubMedGoogle Scholar
  8. (8).
    HIROSE, T., LOU, P. L. — Retinopathy of prematurity. Int. Ophthalmol. Clin., 1986, 26(2), 1–23.PubMedCrossRefGoogle Scholar
  9. (9).
    SOONG, H. K., ELLER, A.W., HIROSE, T., HANNINEN, L., KENYON, K.R. — In situ actin distribution in excised retrolental membranes in retinopathy of prematurity. Arch. Ophthalmol., 1985, 103, 1553–1556.PubMedCrossRefGoogle Scholar
  10. (10).
    SOQUE, J., SANG, D.N., HIROSE, T., ALBERT, D.M., ELLER, A. — Localization of actin in retrolental membranes in retrolental fibroplasia (RLF). Invest. Ophthalmol. Vis. Sci., 1985, 26 (ARVO suppl.), 332.Google Scholar
  11. (11).
    MACHEMER, R. — Description and pathogenesis of late stages of retinopathy of prematurity. Ophthalmology, 1985, 92, 1000–1004.PubMedGoogle Scholar
  12. (12).
    TOLENTINO, F. I., SCHEPENS, C. L., FREEMAN, H. M. — Massive preretinal retraction: a biomicroscopic study. Arch. Ophthalmol., 1967, 78, 16–22.PubMedCrossRefGoogle Scholar
  13. (13).
    MACHEMER, R., LAQUA, H. — Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am. J. Ophthalmol., 1975, 80, 1–23.PubMedGoogle Scholar
  14. (14).
    THE RETINA SOCIETY TERMINOLOGY COMMITTEE. — The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology, 1983, 90, 121–125.Google Scholar
  15. (15).
    FLYNN, J.T., BANCALARI, E., CASSADY, J., SCHIFFMAN, J., GOLDBERG, R., ROBERTS, J. — The influence of continuous transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity (ROP). Invest. Ophthalmol. Vis. Sci., 1986, 27 (ARVO suppl.), 146.Google Scholar
  16. (16).
    HITTNER, H.M., RUDOLPH, A.J., KRETZER, F.L. — Suppression of severe retinopathy of prematurity with vitamin E supplementation: ultrastructural mechanism of clinical efficacy. Ophthalmology, 1984, 91, 1512–1523.PubMedGoogle Scholar
  17. (17).
    NAGATA, M. — Treatment of acute proliferative retrolental fibroplasia with xenon-arc photocoagulation: its indication and limitations. Jpn. J. Ophthalmol., 1977, 21, 436–459.Google Scholar
  18. (18).
    SASAKI, K., YAMASHITA, Y., MAEKAWA, T., ADACHI, T. — Treatment of retinopathy of prematurity in active stage by cryocautery. Jpn. J. Ophthalmol., 1976, 20, 384–395.Google Scholar
  19. (19).
    MCPHERSON, A., HITTNER, H.M. — Sclerai buckling in 21- to 11-month-old premature infants with retinal detachment associated with acute retrolental fibroplasia. Ophthalmology, 1981, 86, 819–836.Google Scholar
  20. (20).
    MACHEMER, R. — Closed vitrectomy for severe retrolental fibroplasia in the infant. Ophthalmology, 1983, 90, 436–441.PubMedGoogle Scholar
  21. (21).
    TRESE, M. T. — Surgical results of stage V retrolental fibroplasia and timing of surgical repair. Ophthalmology, 1984, 91, 461–466.PubMedGoogle Scholar
  22. (22).
    FARIS, B., TOLENTINO, F.I., FREEMAN, H.M., BROCKHURST, R.J., SCHEPENS, C.L. — Retrolental fibroplasia in the cicatricial stage: fundus and vitreous findings. Arch. Ophthalmol., 1971, 85, 661–668.PubMedCrossRefGoogle Scholar
  23. (23).
    FARIS, B.M., BROCKHURST, R.J. — Retrolental fibroplasia in the cicatricial stage: the complication of rhegmatogenous retinal detachment. Arch. Ophthalmol., 1969, 82, 60–65.PubMedCrossRefGoogle Scholar
  24. (24).
    TASMAN, W., ANNESLEY, W. Jr. — Retinal detachment in the retinopathy of prematurity. Arch. Ophthalmol., 1966, 75, 608–614.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • T. Hirose
  • D. N. Sang

There are no affiliations available

Personalised recommendations